Frederick M. Lowery

Chief Executive Officer and Director · Henry Schein

Healthcare Products, Distribution and Technology

Frederick M. Lowery is chief executive officer and a director of Henry Schein. He joined in March 2026 after more than two decades at Thermo Fisher Scientific, where he led laboratory products, customer channels and bioproduction businesses.

Last reviewed: Oct 30, 2026

Frederick M. Lowery

Chief Executive Officer and Director
Henry Schein

Last Reviewed: October 30, 2026

Executive Summary

Frederick M. Lowery is chief executive officer and a director of Henry Schein. He joined in March 2026 after more than two decades at Thermo Fisher Scientific, where he led laboratory products, customer channels and bioproduction businesses.

Career Highlights

  • Joined Henry Schein as chief executive officer and a director on March 2, 2026.
  • Previously led Thermo Fisher Scientific’s Laboratory Products and BioProduction businesses.
  • Began his industrial management career with General Motors and Maytag.

Professional Journey

Lowery worked for General Motors and Maytag before entering the scientific-products industry. In 2005, he joined Fisher Scientific International to lead operations for its Molecular BioProducts business. After Fisher Scientific merged with Thermo Electron in 2006, he became vice president and general manager of Chromatography Consumables and Specialty Glass.

His responsibilities expanded to the Life Science Research business in 2010 and the presidency of Laboratory Consumables in 2011. Thermo Fisher named him senior vice president and president of Laboratory Products in 2014. He added senior operating officer responsibilities for Life Sciences Solutions in 2016 and became president of Life Sciences Solutions and Laboratory Products in 2017.

In January 2021, Lowery became senior vice president and president of Customer Channels. He advanced to executive vice president and president of Laboratory Products and BioProduction in April 2024, overseeing Laboratory Products, Customer Channels and BioProduction. The assignments encompassed distribution and owned-product operations, including manufacturing, research and development, marketing and sales.

Lowery became Henry Schein’s chief executive officer and joined its board on March 2, 2026, succeeding Stanley M. Bergman. His other governance experience includes DuPont’s board and trusteeships at Boston Medical Center, Tennessee Technological University and its foundation.

Education

Lowery earned a Bachelor’s degree in Mechanical Engineering from Tennessee Technological University. Lowery earned a Master’s degree in Manufacturing Management from Kettering University.